Skip to main content
| News

DSM strengthens the Basel Area life sciences cluster

05.11.2020

The global nutrition and health corporation Royal DSM is establishing a new innovation center at the headquarters of Nutritional Products in Kaiseraugst. The Nutrition & Health Campus will be ready in 2023. This gives the Basel Area life sciences cluster a further boost.

The new Nutrition & Health Campus of DSM (Visualization: Nissen Wentzlaff Architekten)

Royal DSM is creating its new Health & Nutrition Campus on the site of Nutritional Products in Kaiseraugst. It will encompass modern research laboratories and collaborative workplaces. Construction is set to begin at the start of 2021 and the building will be ready for use in 2023.

The Campus will bring together more than 200 researchers from the fields of chemicals, formulation, application and analytics. According to a press release, this unites the research & development department with all other innovation activities and business functions to create “the company’s largest global innovation hub”.

When compared with the current situation, which sees employees split across three different buildings, energy consumption for heating will be reduced by 90 percent and electricity use by 80 percent. Transparent bridges will connect the new building and the main existing Nutritional Products global headquarters building. Local landscape designers will be creating a near-natural environment, which will “significantly enhance” the green spaces and biodiversity. The plan is also to incorporate a fully-equipped fitness center for all staff. The campus concept was put together by the Basel office of Nissen Wentzlaff Architekten.

“Our aim is to create a new center of gravity for innovation in the area of nutrition and health, and further strengthen the region in its significance,” commented Thomas Beck, Senior Vice President Innovation. With the construction of the DSM innovation center, the importance of the Basel Area life sciences cluster in particular continues to grow.

The global DSM Nutritional Products Business Group is run out of Kaiseraugst. Local production facilities include manufacturing plants in in Aesch BL, Sisseln AG, Lalden/Visp VS as well as in Baden-Württemberg and in the Alsatian Village-Neuf in the immediate vicinity of Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 60

Do you have a question? We'd like to hear from you.